NALOXONE HYDROCHLORIDE INJECTION USP
NALOXONE HYDROCHLORIDE INJECTION USP
Approved
DIN Number
02548194
Drug Class
Human
Market Date
Sep 26, 2024
Company
HC
sterinova inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02548194
AIG Number0108981002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V03AB15 NALOXONE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
,
Intramuscular
AHFS Classification28:10.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
NALOXONE HYDROCHLORIDEActive
Strength: 0.4 MG / ML
Monograph: NALOXONE HYDROCHLORIDE